Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Graft-Versus-Host Disease

Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation

Bone Marrow Transplantation volume 50, pages 1459–1464 (2015)Cite this article

Subjects

Abstract

We analyzed the incidence and risk factors for ocular GVHD in patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) in Korea. In this retrospective, noncomparative, observational study, 635 subjects were included who had at least 2 years of follow-up ophthalmological examinations after allo-HSCT from 2009 to 2012 at Seoul St Mary’s Hospital, Seoul, Korea. The mean duration between allo-HSCT and onset of ocular GVHD was 225.5±194.3 days. The adjusted incidence for acute ocular GVHD was 1.33% and that for chronic GVHD was 33.33%. In the multivariate analysis, preexisting diabetes mellitus (odds ratio (OR): 4.22, 95% confidence interval (CI): 1.66–10.72), repeated allo-HSCT (OR: 29.10, 95% CI: 1.02–8.28) and the number of organs that chronically developed GVHD by stage I (OR: 14.63, 95% CI: 9.81–21.84) increased risk of ocular GVHD. Careful monitoring of ocular GVHD is needed in patients with chronic GVHD in multiple organs and preexisting diabetes.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Lee SJ, Vogelsang G, Flowers ME . Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003; 9: 215–233.

    Article  CAS  PubMed  Google Scholar 

  2. Sullivan KM, Agura E, Anasetti C, Appelbaum F, Badger C, Bearman S et al. Chronic graft-versus-host disease and other late complications of bone marrow transplantation. Semin Hematol 1991; 28: 250–259.

    CAS  PubMed  Google Scholar 

  3. Ratanatharathorn V, Ayash L, Lazarus HM, Fu J, Uberti JP . Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplant 2001; 28: 121–129.

    Article  CAS  PubMed  Google Scholar 

  4. Dietrich-Ntoukas T, Cursiefen C, Westekemper H, Eberwein P, Reinhard T, Bertz H et al. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD. Cornea 2012; 31: 299–310.

    Article  PubMed  Google Scholar 

  5. Anderson NG, Regillo C . Ocular manifestations of graft versus host disease. Curr Opin Ophthalmol 2004; 15: 503–507.

    Article  PubMed  Google Scholar 

  6. Hessen M, Akpek EK . Ocular graft-versus-host disease. Curr Opin Allergy Clin Immunol 2012; 12: 540–547.

    Article  CAS  PubMed  Google Scholar 

  7. Balaram M, Rashid S, Dana R . Chronic ocular surface disease after allogeneic bone marrow transplantation. Ocul Surf 2005; 3: 203–211.

    Article  PubMed  Google Scholar 

  8. Tichelli A, Duell T, Weiss M, Socié G, Ljungman P, Cohen A et al. Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects. Bone Marrow Transplant 1996; 17: 1105–1111.

    CAS  PubMed  Google Scholar 

  9. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11: 945–956.

    Article  PubMed  Google Scholar 

  10. Jacobs R, Tran U, Chen H, Kassim A, Engelhardt BG, Greer JP et al. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria. Bone Marrow Transplant 2012; 47: 1470–1473.

    Article  CAS  PubMed  Google Scholar 

  11. Kamoi M, Ogawa Y, Dogru M, Uchino M, Kawashima M, Goto E et al. Spontaneous lacrimal punctal occlusion associated with ocular chronic graft-versus-host disease. Curr Eye Res 2007; 32: 837–842.

    Article  PubMed  Google Scholar 

  12. Westeneng AC, Hettinga Y, Lokhorst H, Verdonck L, van Dorp S, Rothova A . Ocular graft-versus-host disease after allogeneic stem cell transplantation. Cornea 2010; 29: 758–763.

    Article  PubMed  Google Scholar 

  13. Ogawa Y, Kuwana M . Dry eye as a major complication associated with chronic graft-versus-host disease after hematopoietic stem cell transplantation. Cornea 2003; 22: S19–S27.

    Article  PubMed  Google Scholar 

  14. Pinschmidt NW . Evaluation of the Schirmer Tear Test. South Med J 1970; 63: 1256 passim.

    Article  PubMed  Google Scholar 

  15. Tabbara KF, Al-Ghamdi A, Al-Mohareb F, Ayas M, Chaudhri N, Al-Sharif F et al. Ocular findings after allogeneic hematopoietic stem cell transplantation. Ophthalmology 2009; 116: 1624–1629.

    Article  PubMed  Google Scholar 

  16. Lee S, Cho BS, Kim SY, Choi SM, Lee DG, Eom KS et al. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease. Biol Blood Marrow Transplant 2007; 13: 1083–1094.

    Article  PubMed  Google Scholar 

  17. Shin SH, Kim JH, Jeon YW, Yoon JH, Yahng SA, Lee SE et al. Feasible outcomes of T cell-replete haploidentical stem cell transplantation with reduced-intensity conditioning in patients with myelodysplastic syndrome. Biol Blood Marrow Transplant 2015; 21: 342–349.

    Article  CAS  PubMed  Google Scholar 

  18. Ivanir Y, Shimoni A, Ezra-Nimni O, Barequet IS . Prevalence of dry eye syndrome after allogeneic hematopoietic stem cell transplantation. Cornea 2013; 32: e97–101.

    Article  PubMed  Google Scholar 

  19. Allan EJ, Flowers ME, Lin MP, Bensinger RE, Martin PJ, Wu MC . Visual acuity and anterior segment findings in chronic graft-versus-host disease. Cornea 2011; 30: 1392–1397.

    Article  PubMed  Google Scholar 

  20. Wang Y, Ogawa Y, Dogru M, Kawai M, Tatematsu Y, Uchino M et al. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease. Bone Marrow Transplant 2008; 41: 293–302.

    Article  CAS  PubMed  Google Scholar 

  21. Atsuta Y, Suzuki R, Yamamoto K, Terakura S, Iida H, Kohno A et al. Risk and prognostic factors for Japanese patients with chronic graft-versus-host disease after bone marrow transplantation. Bone Marrow Transplant 2006; 37: 289–296.

    Article  CAS  PubMed  Google Scholar 

  22. Carlens S, Ringden O, Remberger M, Lönnqvist B, Hägglund H, Klaesson S et al. Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis. Bone Marrow Transplant 1998; 22: 755–761.

    Article  CAS  PubMed  Google Scholar 

  23. Flowers ME, Inamoto Y, Carpenter PA, Lee SJ, Kiem HP, Petersdorf EW et al. Comparative analysis of risk factors for acute graft-versus-host disease and for chronic graft-versus-host disease according to National Institutes of Health consensus criteria. Blood 2011; 117: 3214–3219.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Ozawa S, Nakaseko C, Nishimura M, Maruta A, Cho R, Ohwada C et al. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program. Br J Haematol 2007; 137: 142–151.

    Article  PubMed  Google Scholar 

  25. Anasetti C, Logan BR, Confer DL, Blood and Marrow Transplant Clinical Trials Network. Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med 2012; 367: 1487–1496.

    Article  CAS  PubMed  Google Scholar 

  26. Cutler C, Giri S, Jeyapalan S, Paniagua D, Viswanathan A, Antin JH . Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis. J Clin Oncol 2001; 19: 3685–3691.

    Article  CAS  PubMed  Google Scholar 

  27. Socie G, Schmoor C, Bethge WA, Ottinger HD, Stelljes M, Zander AR et al. Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood 2011; 117: 6375–6382.

    Article  CAS  PubMed  Google Scholar 

  28. Ogawa Y, Shimmura S, Kawakita T, Yoshida S, Kawakami Y, Tsubota K . Epithelial mesenchymal transition in human ocular chronic graft-versus-host disease. Am J Pathol 2009; 175: 2372–2381.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Jabs DA, Wingard J, Green WR, Farmer ER, Vogelsang G, Saral R . The eye in bone marrow transplantation. III. Conjunctival graft-vs-host disease. Arch Ophthalmol 1989; 107: 1343–1348.

    Article  CAS  PubMed  Google Scholar 

  30. Ogawa Y, Yamazaki K, Kuwana M, Farmer ER, Vogelsang G, Saral R . A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci 2001; 42: 111–119.

    CAS  PubMed  Google Scholar 

  31. Griffith ML, Jagasia M, Jagasia SM . Diabetes mellitus after hematopoietic stem cell transplantation. Endocr Pract 2010; 16: 699–706.

    Article  PubMed  Google Scholar 

  32. Radfar M, Faghihi T, Hadjibabaie M, Ebrahimi F, Qorbani M, Iravani M et al. Impact of preexisting diabetes mellitus on transplantation outcomes in hematopoietic stem cell transplantation. Endocr Res 2015; 40: 20–24.

    Article  PubMed  Google Scholar 

  33. Ferraro F, Lymperi S, Mendez-Ferrer S, Saez B, Spencer JA, Yeap BY et al. Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med 2011; 3: 104ra101.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Saraiva J, Sola E, Prieto D, Antunes MJ . Diabetes as an outcome predictor after heart transplantation. Interact Cardiovasc Thorac Surg 2011; 13: 499–504.

    Article  PubMed  Google Scholar 

  35. Sheean PM, Freels SA, Helton WS, Braunschweig CA . Adverse clinical consequences of hyperglycemia from total parenteral nutrition exposure during hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2006; 12: 656–664.

    Article  PubMed  Google Scholar 

  36. Lv H, Li A, Zhang X, Xu M, Qiao Y, Zhang J et al. Meta-analysis and review on the changes of tear function and corneal sensitivity in diabetic patients. Acta Ophthalmol 2014; 92: e96–e104.

    Article  PubMed  Google Scholar 

  37. Ogawa Y, Kim SK, Dana R, Clayton J, Jain S, Rosenblatt MI et al. International Chronic Ocular Graft-vs-Host-Disease (GVHD) Consensus Group: proposed diagnostic criteria for chronic GVHD (Part I). Sci Rep 2013; 3: 3419.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank all the physicians and data managers who contributed their valuable data regarding transplantation. The statistical analyses performed in this article were supervised by the Department of Biostatics at The Catholic University of Korea. This study was funded by the National Research of Korea (2011-0027157) and Korea Health Industry Development Institutes (HI13C0370000). The funding organization had no role in the design or conduct of this research.

Author information

Author notes

  1. K-S Na and Y-S Yoo: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Ophthalmology and Visual Science, Yeouido St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

    K-S Na

  2. Catholic Institutes of Visual Science, The Catholic University of Korea, Seoul, Korea

    Y-S Yoo, J W Mok & C-K Joo

  3. Division of Hematology, Department of Internal Medicine, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

    J W Lee

  4. Department of Ophthalmology and Visual Science, Seoul St Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

    C-K Joo

Authors
  1. K-S Na
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y-S Yoo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J W Mok
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. J W Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. C-K Joo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to C-K Joo.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Na, KS., Yoo, YS., Mok, J. et al. Incidence and risk factors for ocular GVHD after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 50, 1459–1464 (2015). https://doi.org/10.1038/bmt.2015.187

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/bmt.2015.187

This article is cited by

Search

Advanced search

Quick links